Skip to main content

Blog

PPMD Announces Pediatric Certified Duchenne Care Center at Penn State Health Children’s Hospital

...

FDA Accepts Efficacy Supplement to Expand ELEVIDYS Indication

...

WATCH: PTC Therapeutics — EMFLAZA® Landscape in 2024 (Webinar Recording)

...

PPMD Provides $500,000 in Funding to Kinea Bio Through PPMD Venture Pathways Program to Support Next-Gen Midi-Dystrophin Gene Therapy Development

...

Update From PPMD’s 2024 PPMD Duchenne Healthcare Professionals Summit

...

Watch: Dyne Therapeutics — Advancing DYNE-251, an Investigational Medicine for DMD (Webinar Recording)

...

REGENXBIO Announces Completion of Enrollment in Cohort 2 and Additional Positive Interim Data in AFFINITY DUCHENNE® Trial

...

Duchenne Newborn Screening Bill Passes Arizona Senate

...

Watch: Navigating Steroid Choices – Understanding the Process, Pathways, and Policies (Webinar Recording)

...

PPMD 2023 Duchenne Early Care Meeting Report Published: Enhancing Support in Early Diagnosis

...